Profile
Top Tier Capital Partners is a venture capital specialist managing niche-focused funds of funds, secondaries and co-investment strategies. We make primary and secondary investments in venture capital funds and co-invest in select portfolio companies. Our team creates diverse portfolios that are built to spot emerging trends early and to deliver optimal venture returns.
Our value-add lies in our experience, deep networks, industry insights and superior client service. We work collaboratively with our investors to help them build their private equity investment programs, and we partner closely with our managers to offer thoughtful, hands-on counsel. Our team has extensive experience in deal sourcing, due diligence, performance analysis, legal terms negotiation, investment monitoring and reporting. We seek long-lasting, open relationships that begin, not end, with the investment.
Top Tier Capital Partners, LLC (“TTCP”) is not responsible for the content provided on any linked external site and makes no warranties, express or implied, for the accuracy of any content or use of a third-party website and assumes no liability for any errors, inaccuracies, or omissions for third-party website content. While TTCP is providing a link to a third-party website, TTCP does not control, approve, or endorse the website or any of its contents, its sponsor, or any of the policies, activities, products, or services offered on the site or by any advertiser on the site.
Industry
Top Tier Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Top Tier Venture Velocity Fund 4
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
Series B
|
North America
|
$5-10 m
|
$925 M
|
August 2022
|
|
European Investment Fund
|
Fund of funds
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$283 M
|
May 2021
|
|
Top Tier Capital Partners European Venture Capital Fund of Funds
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
HealthTech
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$310 M
|
May 2021
|
|
Top Tier Venture Capital IX-B
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$150 M
|
November 2019
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.